The Competition Commission of India rejected an official complaint lodged against the Health & Family Welfare Department of Odisha, stating the regulator did not find sufficient evidence to open a case. Various parties including medical shop Oracle Drugs issued the complaint against the health department alleging anticompetitive behavior for imposed discounts on healthcare shops at levels higher than initially agreed upon. The department, whose main objective is to provide affordable healthcare, was cleared of any charges as the CCI found the discounts not to be anticompetitive.
Featured News
Trump Administration Defends Pentagon Blacklisting of AI Firm Anthropic in Court Filing
Mar 18, 2026 by
CPI
BMG Sues Anthropic Over Alleged Use of Song Lyrics in AI Training
Mar 18, 2026 by
CPI
Google Proposes New Search Controls Amid UK Competition Scrutiny
Mar 18, 2026 by
CPI
US Appeals Court Revives Whistleblower Case Against Major Drugmakers Over Pricing Program
Mar 18, 2026 by
CPI
Possible Compromise Emerging on Stablecoin Yield Payments in Senate Market-Structure Bill
Mar 18, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Data-Driven Competition
Mar 19, 2026 by
CPI
Data-Driven Competition: Implications For Enforcement and Merger Control
Mar 19, 2026 by
Alexandre de Corniere & Greg Taylor
From Tipping to Trustees: Why Data-Driven Markets Require Institutional Design, Not Optimization
Mar 19, 2026 by
Jens Prüfer & Paul de Bijl
Data Barriers to Entry: What We’ve Learned About Spotting Them and What We Still Don’t Know About Solutions
Mar 19, 2026 by
Bruno Carballa-Smichowski
When the Perfect Is the Enemy of the Good: Price Discrimination, Affordability, Precarity and Market Dynamism
Mar 19, 2026 by
Dan Ciuriak